Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

AbbVie Inc. ABBV

Set alert

Price alert · ABBV

All alert types
294.89 USD +4.10 +1.41%

At close · Oct 30

295.30 +0.41 +0.14%

After hours · Oct 30, 6:40 PM ET

Bid
294.50 × 200
Ask
294.89 × 100
291.01 Day range 298.74
197.38 52-week range 294.89
YTD
+29.06%
1 year
+29.22%
Open
292.00
Prev close
290.79
Mkt cap
521.11B
Vol
6.90M
Avg vol
4.72M
EPS
5.82
P/E
50.67
Div yield
2.38%
More statistics
Low
291.01
High
298.74
Forward P/E
18.15
Beta
0.23
Short ratio
3.22
Inst. own
77.38%
Dividend
6.92
Ex-div date
Oct 14, 2026
Earnings
Feb 3, 2027
50-d avg
268.63
200-d avg
236.73
1y target
283.19

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Feb 4, 2026Earnings: 2.71; estimate 2.65; surprise 2.26%
  • Oct 30, 2026Earnings: 3.82; estimate 3.73; surprise 2.41%
Signals (57)
NameDateAgo
RSI: OverboughtOct 1, 20261 month ago
SMA: BullishJun 1, 20265 months ago
MACD: Buy SignalJun 1, 20265 months ago
SMA: BearishApr 1, 20267 months ago
MACD: Sell SignalApr 1, 20267 months ago
MACD: Buy SignalSep 1, 20251 year ago
SMA: BullishAug 1, 20251 year ago
SMA: BearishMay 1, 20251 year ago
MACD: Sell SignalMay 1, 20251 year ago
SMA: BullishJan 1, 20251 year ago
SMA: BearishDec 1, 20241 year ago
MACD: Buy SignalFeb 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BearishMay 1, 20233 years ago
MACD: Sell SignalJan 1, 20233 years ago
MACD: Buy SignalNov 1, 20224 years ago
SMA: BullishOct 1, 20224 years ago
MACD: Sell SignalSep 1, 20224 years ago
SMA: BearishAug 1, 20224 years ago
RSI: OverboughtJan 1, 20224 years ago
SMA: BullishOct 1, 20215 years ago
SMA: BearishSep 1, 20215 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BearishSep 1, 20206 years ago
SMA: BullishMay 1, 20206 years ago
MACD: Buy SignalMay 1, 20206 years ago
SMA: BullishApr 1, 20206 years ago
SMA: BearishMar 1, 20206 years ago
MACD: Sell SignalMar 1, 20206 years ago
MACD: Buy SignalFeb 1, 20206 years ago
SMA: BearishJan 1, 20206 years ago
SMA: BullishNov 1, 20197 years ago
SMA: BullishOct 1, 20197 years ago
SMA: BearishJan 1, 20197 years ago
SMA: BullishNov 1, 20188 years ago
SMA: BearishOct 1, 20188 years ago
MACD: Sell SignalJul 1, 20188 years ago
SMA: BearishJun 1, 20188 years ago
RSI: OverboughtSep 1, 20179 years ago
MACD: Buy SignalMay 1, 20179 years ago
SMA: BullishMar 1, 20179 years ago
SMA: BullishFeb 1, 20179 years ago
SMA: BearishJan 1, 20179 years ago
SMA: BearishJan 1, 20179 years ago
SMA: BullishNov 1, 201610 years ago
SMA: BearishOct 1, 201610 years ago
SMA: BearishOct 1, 201610 years ago
SMA: BullishApr 1, 201610 years ago
SMA: BullishApr 1, 201610 years ago
SMA: BearishJan 1, 201610 years ago
SMA: BullishOct 1, 201511 years ago
SMA: BearishSep 1, 201511 years ago
SMA: BearishAug 1, 201511 years ago
RSI: OverboughtJul 1, 201511 years ago
SMA: BullishApr 1, 201511 years ago
SMA: BearishMar 1, 201511 years ago
RSI: OverboughtSep 1, 201412 years ago

Financial health

Altman Z-Score

2.90 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 96.4×
FY 2016: 17.2×FY 2017: 29.2×FY 2018: 25.0×FY 2019: 16.7×FY 2020: 39.2×FY 2021: 20.9×FY 2022: 24.3×FY 2023: 56.8×FY 2024: 74.0×FY 2025: 96.4×
FY 2016 5y median 56.8× FY 2025
P/S 6.6×
FY 2016: 4.0×FY 2017: 5.5×FY 2018: 4.3×FY 2019: 3.9×FY 2020: 3.9×FY 2021: 4.3×FY 2022: 4.9×FY 2023: 5.0×FY 2024: 5.6×FY 2025: 6.6×
FY 2016 5y median 5.0× FY 2025
P/B -124×
FY 2016: 21.9×FY 2017: 30.3×FY 2018: -16.8×FY 2019: -16.0×FY 2020: 13.7×FY 2021: 15.6×FY 2022: 16.6×FY 2023: 26.4×FY 2024: 94.5×FY 2025: -124×
FY 2016 5y median 16.6× FY 2025
P/FCF 22.8×
FY 2016: 15.5×FY 2017: 16.4×FY 2018: 11.1×FY 2019: 10.3×FY 2020: 10.6×FY 2021: 10.9×FY 2022: 11.8×FY 2023: 12.4×FY 2024: 17.6×FY 2025: 22.8×
FY 2016 5y median 12.4× FY 2025
EV/EBITDA 26.6×
FY 2016: 13.2×FY 2017: 17.6×FY 2018: 21.1×FY 2019: 12.9×FY 2020: 20.9×FY 2021: 12.8×FY 2022: 14.1×FY 2023: 18.7×FY 2024: 25.3×FY 2025: 26.6×
FY 2016 5y median 18.7× FY 2025
EV/Sales 7.7×
FY 2016: 5.2×FY 2017: 6.5×FY 2018: 5.3×FY 2019: 4.8×FY 2020: 5.6×FY 2021: 5.5×FY 2022: 5.9×FY 2023: 5.9×FY 2024: 6.7×FY 2025: 7.7×
FY 2016 5y median 5.9× FY 2025
FCF Yield 4.4%
FY 2016: 6.5%FY 2017: 6.1%FY 2018: 9.0%FY 2019: 9.7%FY 2020: 9.4%FY 2021: 9.2%FY 2022: 8.5%FY 2023: 8.1%FY 2024: 5.7%FY 2025: 4.4%
FY 2016 5y median 8.1% FY 2025

Profitability

Gross Margin 70.2%
FY 2016: 77.2%FY 2017: 75.0%FY 2018: 76.4%FY 2019: 77.6%FY 2020: 66.4%FY 2021: 69.0%FY 2022: 70.0%FY 2023: 62.4%FY 2024: 70.0%FY 2025: 70.2%
FY 2016 5y median 70.0% FY 2025
Operating Margin 32.8%
FY 2016: 36.4%FY 2017: 33.8%FY 2018: 19.5%FY 2019: 39.0%FY 2020: 24.8%FY 2021: 31.9%FY 2022: 31.2%FY 2023: 23.5%FY 2024: 16.2%FY 2025: 32.8%
FY 2016 5y median 31.2% FY 2025
Net Margin 6.9%
FY 2016: 23.2%FY 2017: 18.8%FY 2018: 17.4%FY 2019: 23.7%FY 2020: 10.1%FY 2021: 20.5%FY 2022: 20.4%FY 2023: 9.0%FY 2024: 7.6%FY 2025: 6.9%
FY 2016 5y median 9.0% FY 2025
ROE -129.2%
FY 2016: 128.4%FY 2017: 104.2%FY 2018: -67.3%FY 2019: -96.5%FY 2020: 35.3%FY 2021: 74.9%FY 2022: 68.6%FY 2023: 46.9%FY 2024: 128.7%FY 2025: -129.2%
FY 2016 5y median 68.6% FY 2025
ROIC 13.0%
FY 2016: 12.4%FY 2017: 10.8%FY 2018: 13.5%FY 2019: 15.7%FY 2020: 8.7%FY 2021: 12.9%FY 2022: 14.0%FY 2023: 9.6%FY 2024: 8.9%FY 2025: 13.0%
FY 2016 5y median 12.9% FY 2025
ROA 3.2%
FY 2016: 9.0%FY 2017: 7.5%FY 2018: 9.6%FY 2019: 8.8%FY 2020: 3.1%FY 2021: 7.9%FY 2022: 8.5%FY 2023: 3.6%FY 2024: 3.2%FY 2025: 3.2%
FY 2016 5y median 3.6% FY 2025

Growth (YoY)

Revenue 8.6%
FY 2016: 12.2%FY 2017: 10.1%FY 2018: 16.1%FY 2019: 1.6%FY 2020: 37.7%FY 2021: 22.7%FY 2022: 3.3%FY 2023: -6.4%FY 2024: 3.7%FY 2025: 8.6%
FY 2016 FY 2025
Operating Income 119.9%
FY 2016: 23.9%FY 2017: 2.2%FY 2018: -33.1%FY 2019: 103.4%FY 2020: -12.5%FY 2021: 57.7%FY 2022: 1.1%FY 2023: -29.6%FY 2024: -28.4%FY 2025: 119.9%
FY 2016 FY 2025
EPS (diluted) -0.8%
FY 2016: 16.0%FY 2017: -9.1%FY 2018: 11.5%FY 2019: 43.5%FY 2020: -48.5%FY 2021: 137.1%FY 2022: 2.8%FY 2023: -59.0%FY 2024: -12.1%FY 2025: -0.8%
FY 2016 FY 2025
Free Cash Flow -0.1%
FY 2016: -6.3%FY 2017: 43.7%FY 2018: 35.6%FY 2019: -0.1%FY 2020: 31.5%FY 2021: 31.0%FY 2022: 10.3%FY 2023: -9.0%FY 2024: -19.2%FY 2025: -0.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.7×
FY 2016: 1.7×FY 2017: 1.3×FY 2018: 1.0×FY 2019: 3.2×FY 2020: 0.8×FY 2021: 0.8×FY 2022: 1.0×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 0.7×
FY 2016 5y median 0.8× FY 2025
Quick Ratio 0.6×
FY 2016: 1.5×FY 2017: 1.2×FY 2018: 0.9×FY 2019: 3.1×FY 2020: 0.7×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.7× FY 2025
Debt / Equity -21.1×
FY 2016: 7.9×FY 2017: 7.3×FY 2018: -4.8×FY 2019: -8.2×FY 2020: 6.7×FY 2021: 5.0×FY 2022: 3.7×FY 2023: 5.8×FY 2024: 20.4×FY 2025: -21.1×
FY 2016 5y median 5.0× FY 2025
Net Debt / EBITDA 3.6×
FY 2016: 3.1×FY 2017: 2.7×FY 2018: 4.0×FY 2019: 2.2×FY 2020: 6.4×FY 2021: 2.8×FY 2022: 2.3×FY 2023: 2.8×FY 2024: 4.2×FY 2025: 3.6×
FY 2016 5y median 2.8× FY 2025
Interest Coverage 6.9×
FY 2016: 8.9×FY 2017: 8.3×FY 2018: 4.7×FY 2019: 7.3×FY 2020: 4.6×FY 2021: 7.4×FY 2022: 8.1×FY 2023: 5.7×FY 2024: 3.3×FY 2025: 6.9×
FY 2016 5y median 6.9× FY 2025

Dividends

Dividend Yield 2.9%
FY 2016: 3.7%FY 2017: 2.7%FY 2018: 3.9%FY 2019: 4.9%FY 2020: 4.3%FY 2021: 3.9%FY 2022: 3.5%FY 2023: 3.8%FY 2024: 3.5%FY 2025: 2.9%
FY 2016 5y median 3.5% FY 2025
Payout Ratio 275.8%
FY 2016: 62.4%FY 2017: 77.4%FY 2018: 98.1%FY 2019: 80.8%FY 2020: 167.2%FY 2021: 80.2%FY 2022: 84.9%FY 2023: 216.7%FY 2024: 257.7%FY 2025: 275.8%
FY 2016 5y median 216.7% FY 2025

Annual · latest fiscal year ends 2025-12-31